← Eichor
Study identifier: NCT07214844 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain

Condition: Low Back Pain, Chronic  ·  Sponsor: Montefiore Medical Center

PhaseNA
Planned participants110
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A research study is being conducted to compare two treatments for long-term low back pain: * One uses the iovera° system, which applies cold to certain nerves in the lower back. * The other is the standard treatment called radiofrequency ablation, which uses heat. The primary objective is to find out which treatment works better to reduce back pain. Participants in this study will be randomly placed in one of the two treatment groups. The clinical research team will check on participant pain levels and overall health before and after the procedure for about 12 months. The entire study will last about 14 months for each participant.

This description comes directly from the study's public registry record.

Talk to the study team

Karina Gritsenko, MD  ·  609-369-0344  ·  kgritsen@montefiore.org

Rafi Khandaker, BA  ·  9297152343  ·  rkhandaker@montefiore.org

Always discuss trial participation with your own doctor first.

Locations (1)

Montefiore Multidisciplinary Pain ProgramThe Bronx, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07214844